Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17476007 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting 1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Condition: Osteoporosis
Intervention: Drug: zoledronic acid
2 Completed HORIZON-PFT: Pivotal Fracture Trial
Condition: Osteoporosis
Intervention: Drug: Zoledronic Acid

Indicates status has not been verified in more than two years